Landmark Huntington's trial starts

A clinical study, led by Professor Sarah Tabrizi (UCL Neurodegenerative Diseases), has trialled the first drug that can potentially correct the underlying defect that causes Huntington's disease. Read: BBC News, More: Times (£), UCL News